Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	571.62	-34.93	5.20
Graham Fair Price	3.61	8.69	8.39
PEG	17.85	1.24	-1.05
Price/Book	32.62	1.23	0.93
Price/Cash Flow	111679.40	615.80	0.55
Prices/Earnings	24.78	7.28	5.83
Price/Sales	20.72	7.79	6.45
Price/FCF	111679.40	615.80	0.55
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	35.32	0.52	0.38
ROA	3.42	< 0.005	< 0.005
ROE	0.04	0.04	6.28
ROIC	< 0.005	0.02	74.01
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.07	-0.02	193.54
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	-0.14	0.50	262.58
EPS QOQ	-0.06	0.06	5.88
FCF QOQ	18.50	-1.00	-94.60
Revenue QOQ	-0.20	0.11	-46.30
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	469.32	0.00	inf
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.76	0.70	-8.62
Quick Ratio	0.46	62.95	13653.79
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	8.86	8.91	0.51
Cash	27.81	28.84	3.70
Capex	-0.06	-0.07	-9.62
Free Cash Flow	14.94	0.02	-99.88
Revenue	1.28	1.41	10.42
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.37	6.05	1538.56
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-9.77	34.61	254.05
Naive Interpretation	Member

06 - Financial Health · Bad

Rating